Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
NCT02676310 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 53
Last updated 2017-03-17
Summary
This is a safety, tolerability, and pharmacokinetics study of bimatoprost in male patients with androgenetic alopecia (AGA).
Conditions
- Alopecia
- Alopecia, Androgenetic
- Baldness
Interventions
- DRUG
-
Bimatoprost
Sponsors & Collaborators
-
Allergan
lead INDUSTRY
Principal Investigators
-
Medical Director · Allergan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2017-01-31
- Completion
- 2017-03-31
Countries
- United States
Study Locations
More Related Trials
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
NCT01325350 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing
NCT02503137 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of KX826 in Healthy Male Subjects With Androgenetic Alopecia Following Topical Single Ascending Dose Administration
NCT04984707 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Bimatoprost Effect on Androgen Dependent Hair Follicles
NCT02170662 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
NCT02275351 ·Status: COMPLETED ·Phase: PHASE2
-
the Safety, Tolerability and PK of KX-826 in Healthy Males With Alopecia Following Topical Multiple Dose Ascending
NCT04502901 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic Alopecia
NCT02279823 ·Status: COMPLETED ·Phase: PHASE2
-
An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
NCT06556056 ·Status: COMPLETED ·Phase: NA
-
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
NCT05417308 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
NCT00418730 ·Status: COMPLETED ·Phase: PHASE2
-
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191 ·Status: COMPLETED ·Phase: NA
-
To Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic Alopecia
NCT05218642 ·Status: COMPLETED ·Phase: PHASE2
-
Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
NCT05802173 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
NCT04913519 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
NCT05910450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Various Procedural Treatment Options for Androgenetic Alopecia
NCT06826001 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia
NCT00958750 ·Status: COMPLETED ·Phase: PHASE3
-
Topical 5% Minoxidil and Potent Topical Corticosteroid Versus Intralesional Corticosteroid in the Treatment of Alopecia Areata
NCT03535233 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
NCT01501617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution
NCT03495817 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.
NCT05599243 ·Status: COMPLETED ·Phase: PHASE2
-
Minoxidil 5% / Botanical Hair Regimen in Men With Thinning Hair and Male Pattern Hair Loss/Androgenic Alopecia
NCT02460289 ·Status: COMPLETED ·Phase: NA
-
A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males
NCT02781311 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
NCT05244980 ·Status: COMPLETED ·Phase: PHASE1
-
Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss
NCT06590779 ·Status: NOT_YET_RECRUITING ·Phase: NA